top
 
Join "Team WIA" at the Race for the Cure
 
Search      
Subscribe to Our Newsletter
Enter your e-mail address to
receive our newsletter
Latest News
Teresa Heinz: Get that mammogram
Read More
A letter from Susan Komen foundation
Read More
Susan G. Komen for the Cure Recommends No Impediments to Breast Cancer Screening
Read More
View All
 
 

BSGI / Breast Specific Gamma Imaging

Dilon brochure

Performed with the Dilon 6800 Gamma Camera, Breast-Specific Gamma Imaging (BSGI) - sometimes called Molecular Breast Imaging - is an excellent problem-solving tool for questionable findings on mammography or breast ultrasound. It can also be helpful for evaluating areas of palpable concern when the mammogram and ultrasound are normal.

This molecular imaging technique has a high sensitivity for the early detection of breast cancer with infrequent false-positive results. Because the interpretation of BSGI is not affected by breast tissue density, it is an ideal diagnostic complement to mammography.

Medicare and most private insurance companies cover BSGI under standard nuclear breast imaging codes.

In May 2007, Weinstein Imaging Associates became the first facility in western Pennsylvania and the entire Pittsburgh tri-state region to offer this service.

 




Dilon brochure Dilon brochure Dilon brochure
Click on images to view the rest of
the Dilon brochure on BSGI
 

 


 About Dilon Technologies

Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, compact gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

 Comparison of Breast Imaging Modalities

 
Mammography
Ultrasound
MRI
BSGI
Normal Breast        
Sensitivity
High
Variable
High
High
Specificity
Low
Medium
Variable
High
Dense Breast        
Sensitivity
Medium
Variable
High
High
Specificity
Low
Medium
Variable
High

Key: Low - less than 40%, Medium - 40 to 80%, High - greater than 80%, Variable - referenced range varies by more than 30%.

© Copyright 2007 Dilon Technologies

BSGI Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ
11/30/2009

GammaLoc cleared by FDA!
Dilon Diagnostics, December 2009

Molecular-based Breast Imaging:  Catching Up to Breast MRI
BSGI is positioned along side MRI in the diagnostic protocol

Dr. Kristen Brill, breast surgeon at Thomas Jefferson University Hospital, refers to BSGI as "an aide in determining the extent of breast disease"
 
The Breast Journal article showing that BSGI and MRI have similar sensitivities, but BSGI has higher specificity than MRI.

Academic Radiology article showing that BSGI has better sensitivity than MRI or mammography for detecting ductal carcinoma in situ (DCIS).

Our press release about BSGI, which includes photos and video clips of this new test.

Various media articles about
our role in introducing BSGI to the Pittsburgh region.

April 2008 article showing that BSGI found breast cancer in 2% of women with normal mammograms.

Radio ad on KDKA-AM featuring BSGI usage in our practice.

BSGI May Reduce Unnecesary Biopsies
BSGI may eliminate the need for up to 50% of biopsies.

Building a Case for BSGI
Two new research studies show that for specific cancers BSGI is a valuable tool.

 
 

 

 

 

 

 

     
 
Copyright 2004-09 Weinstein Imaging Associates
Home | About Us | For Patients | For Doctors | News / Events | Links | Contact Us